U.S. Markets close in 57 mins

How Analysts View Allergan after Its 1Q18 Earnings

Mike Benson
How Analysts View Allergan after Its 1Q18 Earnings

Allergan (AGN) surpassed Wall Street analysts’ estimates for earnings per share (or EPS) and revenues, reporting EPS of $3.74 on revenues of $3.7 billion during 1Q18. Analysts expect Allergan’s top line to fall 3.3% to ~$3.9 billion in 2Q18. Its earnings per share are expected to reach $4.03 in 2Q18. The chart below shows analysts’ recommendations over the last 12 months.